Have you taken Neurontin and suffered severe side
effects, including suicidal behavior? Contact Ken Nunn,
The Indiana Injury Lawyer, immediately at 1-800-CALL-KEN and GET HELP NOW! online.
I cover Vanderburgh County,
Saint Joseph County,
and the rest of the state. I have represented over 20,000 clients
in 574 different cities in Indiana for more than 42 years. I go toe-to-toe with
large businesses and insurance companies on a daily basis. I know all the tricks
they pull to try to keep you and your family from winning the compensation that
you deserve. They'd like nothing better than to give you a tiny check for your
injuries. Don't let them do it! File a Neuronton lawsuit for you.
Known generically as gabapentin, Neurontin first received Food and Drug Administration
(FDA) approval in 1993 as an "adjunctive therapy" for patients suffering from epilepsy.
However, off-label marketing for Neurontin by its manufacturer, Pfizer, has been a
serious problem. Although it is not illegal for a doctor to prescribe a drug for
conditions outside of those for which it was approved, it is illegal for a drug
company to market a medication for off-label uses. Pfizer has been accused of
deliberately forming a plan to persuade doctors to prescribe Neurontin as an
off-label treatment for:
Restless Leg Syndrome (RLS)
Pain Syndromes, Peripheral Neuropathy, and Diabetic Neuropathy
Treatment of Epilepsy alone (as monotherapy)
Drug and Alcohol Withdrawal Seizures
Reflex Sympathetic Dystrophy (RSD)
Attention Deficit Disorder (ADD)
Essential Tremor Periodic Limb Movement
Post-Hepatic Neuralgia (PHN)
These eleven uses were never submitted to the FDA for approval, yet were
promoted – illegally. State and federal prosecutors launched investigations
into the allegedly illegal marketing of Neurontin, leading Pfizer to admit
“that it aggressively marketed [Neurontin] by illicit means for unrelated
conditions.” So far, Pfizer has agreed to pay $430 million dollars in penalties
and has entered a corporate integrity agreement promising to use better
marketing practices in the future.
In addition to the off-label use issues, Neurontin was included in a review
of about 200 different clinical studies involving nearly 44,000 individuals
taking certain epilepsy drugs, which found that users were twice as likely to
experience suicidal behavior. The FDA has issued a warning of an increased
risk of suicidal thoughts and behaviors in patients taking Neurontin. The
approved label for Neurontin now includes a warning about an increased risk of
suicidal thoughts or actions and a guide to help patients understand this risk.
Prescription drug injuries have a huge impact on your life and your families.
Put a fighter on your side and show these drug companies that they can't get
away with selling defective products. I am Ken Nunn, The Indiana Injury Lawyer.
Contact me today to receive a free consultation on your Neurontin case. You can GET HELP NOW!
online by filling out a quick and easy form or you can call my office at
1-800-CALL-KEN. The initial consultation is free and the
clock is running, so don't delay. Call now!